[Retracted] Aspirin inhibits growth of ovarian cancer by upregulating caspase-3 and downregulating bcl-2
Affiliations: Department of Gynaecology and Obstetrics, Xiangyan Central Hospital, Hubei University of Arts and Science, Xiangyang, Hubei 441021, P.R. China, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China, Dongfang Hospital, The Second Clinical Medical College of Beijing University of Chinese Medicine (BUCM), Beijing 100078, P.R. China, School of Life Sciences, Fudan Univesity, Shanghai 200433, P.R. China
- Published online on: March 4, 2019 https://doi.org/10.3892/ol.2019.10108
- Pages: 4742-4742
Copyright : © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Oncol Lett 12: [Related article:] 93-96, 2016; DOI: 10.3892/ol.2016.4607
We would like to retract our article entitled “Aspirin inhibits growth of ovarian cancer by upregulating caspase-3 and downregulating bcl-2”, published in Oncology Letters 12, 93–96, 2016, for the following reasons. First, we found that certain of the results of the study were too preliminary. Secondly, the p53N236S mice were obtained from an unreliable source, and therefore their genetic background may have been uncertain, which could have added to the lack of confidence in the results. Lastly, the manuscript was completed and submitted by the first author, Lin Li, without the prior consent of the other listed co-authors and the corresponding author. The last three co-authors (FD, XJ and WZ) have confirmed that they were not aware of being listed as co-authors, and they were not involved either in the research or in submission process.
As a result, we have decided to retract the article from publication. All the named authors agree to this retraction. We sincerely apologize for any inconvenience that might result from the retraction of this article.